Smartphones for Opiate Addiction Recovery (SOAR)

This is an interventional treatment trial for Opioid-use Disorder Read More

Inclusion Criteria:

Patients:

• Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids);
• Have entered, or expressed a clear intention to enter, an OUD treatment program that prescribes either methadone or buprenorphine
• Any gender;
• 18 years of age and older;
• Have used opioids other than as specifically prescribed within thirty days prior to consent;
• In good-enough general health;
• Capacity to provide written informed consent as assessed by our Subject Comprehension Assessment Tool(subjects lacking the ability to consent will not be enrolled) ;
• Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study.

Study-Physician Participants.

• Licensed MD employed by the respective site, or at a clinical partner of the respective site, where they will act as participants and be part of the treatment team
• Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
• Able to speak, read, and write English fluently and to provide informed consent in English

Clinician Participants.

• Licensed MSW, NP, or MD; who are not part of any treatment team within the study and may be employees of their respective sites or other treatment facilities.
• Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
• Able to speak, read, and write English fluently and to provide informed consent in English

Exclusion Criteria:

Patients:

• Serious medical, psychiatric or non-opioid substance use disorder that, in the opinion of a study physician, would make study participation hazardous to the participant or compromise study findings or would prevent the participant from completing the study. Examples include: (a) Disabling or terminal medical illness (e.g., uncompensated heart failure, cirrhosis or end-stage liver disease) as assessed by medical history, review of systems, physical exam and/or laboratory assessments;
• Severe, untreated or inadequately treated mental disorder (e.g., active psychosis, uncontrolled manic-depressive illness) as assessed by history and/or clinical interview;
• Current severe alcohol, benzodiazepine, or other depressant or sedative hypnotic use likely to require a complicated medical detoxification (routine alcohol and sedative detoxifications may be included);
• Suicidal or homicidal ideation that requires immediate attention;
• Presence of pain of sufficient severity as to require ongoing pain management with opioids;
• Pending legal action or other reasons that might prevent an individual from completing the study.
• Pregnancy as assessed by urine pregnancy testing
• Breastfeeding of infants, as assessed by self-report.
• Prisoners, as defined by OHRP, are excluded from participation in the study.
• Individuals receiving residential court-ordered substance abuse treatment.

Study-Physician Participants.

• none

Clinician Participants.

• none